Compugen Ltd. (CGEN)
Nasdaq: CGEN · Biological Products, (No Diagnostic Substances) · Holon, IL · filing with the SEC since 2001
Who runs Compugen Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Ophir Eran
President and CEO. First filing Mar 2026, latest Jul 30, 2026, 3 filings in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
13 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ophir Eran | President and CEO | Mar 2026 | Jul 30, 2026 | 3 · $0.00 |
| Silberman David | Chief Financial Officer | Mar 2026 | Jul 30, 2026 | none |
| Ferre Pierre | Chief Operating Officer | Mar 2026 | Jul 30, 2026 | none |
| Mahler Michelle | Chief Medical Officer | Mar 2026 | Jul 30, 2026 | none |
| Kredo Russo Sharon | SVP, Research & Discovery | Mar 2026 | Jul 30, 2026 | none |
| Levine Zurit | SVP, Business Development | Mar 2026 | Jul 30, 2026 | 9 · $100,000 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cohen-Dayag Anat | director | Mar 2026 | Jul 30, 2026 | none |
| Halevy Gilead | director | Mar 2026 | Jul 30, 2026 | none |
| Hukkelhoven Mathias | director | Mar 2026 | Jul 30, 2026 | none |
| Livnat Savitzky Kinneret | director | Mar 2026 | Jul 30, 2026 | none |
| Perry Eran | director | Mar 2026 | Jul 30, 2026 | none |
| Zweifach Sanford S | director | Mar 2026 | Jul 30, 2026 | none |
| Holcomb Michele | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.